Académique Documents
Professionnel Documents
Culture Documents
Leukemia Research
journal homepage: www.elsevier.com/locate/leukres
3. Discussion
Alemtuzumab is an IgG monoclonal antibody directed against
the CD52 antigen. This antigen is mainly expressed on T lympho-
e155
e156
[12]
[13]
[14]
[15]
[16]
[17]
[18]
[19]
[20]
[21]
[22]